US Broker Ratings

Bioventus Inc. (BVS) Stock Analysis: Exploring an 89% Potential Upside in the Medical Device Sector

Bioventus Inc. (NASDAQ: BVS) sits at a pivotal intersection of the healthcare and medical device sectors, offering a diverse array of products aimed at alleviating pain..

Claritev Corporation (CTEV) Stock Analysis: Navigating the Healthcare Data Landscape Amidst a Volatile Market

Claritev Corporation (NASDAQ: CTEV), a key player in the healthcare sector, focuses on delivering data analytics and technology-enabled solutions that streamline cost management, payment, and revenue..

Verve Therapeutics, Inc. (VERV): Analyst Ratings Suggest a Potential 455% Upside for This Biotech Innovator

Verve Therapeutics, Inc. (NASDAQ: VERV), a pioneering entity in the biotechnology sector, is making waves with its cutting-edge gene editing solutions aimed at tackling cardiovascular diseases...

SIGA Technologies Inc. (SIGA) Stock Analysis: Evaluating the Value Proposition Amidst Healthcare Sector Challenges

For investors seeking opportunities in the healthcare sector, SIGA Technologies Inc. (SIGA) presents a unique proposition. Based in New York, SIGA is a commercial-stage pharmaceutical company..

AngioDynamics, Inc. (ANGO) Investor Outlook: Assessing the 66.49% Potential Upside Amidst Current Market Challenges

AngioDynamics, Inc. (ANGO), a noteworthy player in the healthcare sector, specifically within the medical instruments and supplies industry, is capturing investor attention with its promising potential..

Eton Pharmaceuticals, Inc. (ETON) Stock Analysis: A 43% Upside Potential in the Healthcare Sector

Eton Pharmaceuticals, Inc. (ETON), a burgeoning player in the healthcare sector, is captivating investor attention with its focus on rare disease treatments and a promising growth..

Treace Medical Concepts, Inc. (TMCI) Investor Outlook: Navigating a 59% Potential Upside in the Healthcare Sector

As a player in the burgeoning medical device industry, Treace Medical Concepts, Inc. (NASDAQ: TMCI) is making waves with its innovative solutions for bunion correction. This..

Cel-Sci Corporation (CVM) Stock Analysis: A Biotech Play with a Staggering Potential Upside of 9,657%

Cel-Sci Corporation (NYSE: CVM) has captured the attention of investors with its eye-popping potential upside of 9,657%, according to analyst target price ranges. This biotechnology firm,..

Cross Country Healthcare, Inc. (CCRN) Stock Analysis: A 33.75% Potential Upside Amidst Challenging Metrics

Cross Country Healthcare, Inc. (NASDAQ: CCRN) stands as a pivotal player in the healthcare staffing industry, offering a breadth of talent management services across the United..

MeiraGTx Holdings plc (MGTX) Stock Analysis: Exploring a Potential 354.55% Upside in Gene Therapy Innovations

MeiraGTx Holdings plc (NASDAQ: MGTX), a dynamic player in the biotechnology sector, is making waves with its focus on genetic medicine innovations, despite the inherent challenges..

Organogenesis Holdings Inc. (ORGO) Stock Analysis: A 110% Upside Potential Amidst Challenging Metrics

Organogenesis Holdings Inc. (NASDAQ: ORGO) stands at a pivotal crossroads, intriguing investors with its potential for significant upside, despite some challenging performance metrics. With its market..

Standard BioTools Inc. (LAB) Stock Analysis: Unlocking Potential with a 148.82% Upside

For investors eyeing opportunities in the healthcare sector, Standard BioTools Inc. (NASDAQ: LAB) presents a compelling narrative characterized by innovative technology and significant potential upside. At..

Maze Therapeutics, Inc. (MAZE): Investor Outlook with 145% Potential Upside

Maze Therapeutics, Inc. (NASDAQ: MAZE) is catching the eye of investors with its promising pipeline and substantial growth potential within the biotechnology sector. Based in South..

Fortrea Holdings Inc. (FTRE) Stock Analysis: A 59.69% Upside Opportunity in the Healthcare Sector

Fortrea Holdings Inc. (FTRE), a recently established player in the healthcare sector, is capturing attention for its potential upside of nearly 60%, a figure that could..

Kamada Ltd. (KMDA) Stock Analysis: Unveiling a Potential 118% Upside in the Healthcare Sector

For investors with an eye on the healthcare sector, Kamada Ltd. (NASDAQ: KMDA) presents a compelling opportunity. Headquartered in Rehovot, Israel, this specialty and generic drug..

Celcuity Inc. (CELC) Stock Analysis: Exploring a 165% Potential Upside in Biotechnology

For investors with a keen eye on the biotechnology sector, Celcuity Inc. (NASDAQ: CELC) presents an intriguing opportunity. This clinical-stage biotech company, headquartered in Minneapolis, Minnesota,..

Autolus Therapeutics (AUTL) Stock Analysis: Exploring a Potential 551% Upside in Biotech

Autolus Therapeutics plc (NASDAQ: AUTL) is capturing investor attention with its significant potential upside of over 551%, according to analyst ratings. As a clinical-stage biopharmaceutical company,..

Sionna Therapeutics, Inc. (SION) Stock Analysis: A Potential 195.93% Upside in Biotech Innovation

Sionna Therapeutics, Inc. (NASDAQ: SION), a burgeoning player in the biotechnology sector, is capturing investor attention with its promising pipeline and significant upside potential. Despite its..

Capricor Therapeutics, Inc. (CAPR): Biotech Pioneer with 287.89% Potential Upside

Capricor Therapeutics, Inc. (NASDAQ: CAPR), a clinical-stage biotechnology company, has captured the attention of investors with a remarkable potential upside of 287.89%. Specializing in transformative cell..

LifeMD, Inc. (LFMD) Stock Analysis: Telehealth Powerhouse with 48.8% Revenue Growth and Analyst Optimism

LifeMD, Inc. (NASDAQ: LFMD) is making significant strides in the healthcare sector, particularly within the burgeoning field of telehealth. With a market capitalization of $522.65 million,..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds